rs766515922

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_024915.4(GRHL2):​c.685C>T​(p.Arg229Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000109 in 1,461,484 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R229Q) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

GRHL2
NM_024915.4 missense

Scores

1
11
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 5.09

Publications

1 publications found
Variant links:
Genes affected
GRHL2 (HGNC:2799): (grainyhead like transcription factor 2) The protein encoded by this gene is a transcription factor that can act as a homodimer or as a heterodimer with either GRHL1 or GRHL3. Defects in this gene are a cause of non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28).[provided by RefSeq, Mar 2009]
GRHL2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 28
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: STRONG Submitted by: ClinGen
  • posterior polymorphous corneal dystrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
  • nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital fibrosis of extraocular muscles
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRHL2NM_024915.4 linkc.685C>T p.Arg229Trp missense_variant Exon 5 of 16 ENST00000646743.1 NP_079191.2
GRHL2NM_001330593.2 linkc.637C>T p.Arg213Trp missense_variant Exon 5 of 16 NP_001317522.1
GRHL2NM_001440448.1 linkc.637C>T p.Arg213Trp missense_variant Exon 5 of 16 NP_001427377.1
GRHL2NM_001440447.1 linkc.685C>T p.Arg229Trp missense_variant Exon 5 of 16 NP_001427376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRHL2ENST00000646743.1 linkc.685C>T p.Arg229Trp missense_variant Exon 5 of 16 NM_024915.4 ENSP00000495564.1
GRHL2ENST00000395927.1 linkc.637C>T p.Arg213Trp missense_variant Exon 5 of 16 2 ENSP00000379260.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000199
AC:
5
AN:
251366
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000109
AC:
16
AN:
1461484
Hom.:
0
Cov.:
30
AF XY:
0.00000825
AC XY:
6
AN XY:
727054
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000299
AC:
1
AN:
33466
American (AMR)
AF:
0.000112
AC:
5
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39666
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000720
AC:
8
AN:
1111712
Other (OTH)
AF:
0.00
AC:
0
AN:
60374
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.00000263657), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.394
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 05, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Arg229Trp variant in GRHL2 has not been previously reported in individuals with hearing loss, but has been identified in 1/16506 South Asian chromosomes a nd 1/11564 Latino chromosomes by the Exome Aggregation Consortium (ExAC, http:// exac.broadinstitute.org; dbSNP rs766515922). Although this variant has been seen in the general population, its frequency is not high enough to rule out a patho genic role. Computational prediction tools and conservation analysis do not prov ide strong support for or against an impact to the protein. In summary, the clin ical significance of the p.Arg229Trp variant is uncertain. -

not provided Uncertain:1
Feb 02, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is present in population databases (rs766515922, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with GRHL2-related conditions. ClinVar contains an entry for this variant (Variation ID: 504944). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 229 of the GRHL2 protein (p.Arg229Trp). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Uncertain
0.043
T
BayesDel_noAF
Uncertain
0.050
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.29
T;T;.
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.96
.;D;D
M_CAP
Benign
0.019
T
MetaRNN
Uncertain
0.53
D;D;D
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.2
M;M;.
PhyloP100
5.1
PrimateAI
Uncertain
0.69
T
PROVEAN
Uncertain
-2.8
D;.;D
REVEL
Benign
0.28
Sift
Uncertain
0.021
D;.;D
Sift4G
Benign
0.16
T;.;T
Polyphen
0.21
B;B;.
Vest4
0.72
MutPred
0.63
Loss of disorder (P = 0.0347);Loss of disorder (P = 0.0347);.;
MVP
0.35
MPC
1.1
ClinPred
0.99
D
GERP RS
5.3
Varity_R
0.23
gMVP
0.56
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs766515922; hg19: chr8-102582573; COSMIC: COSV104573581; API